Efficacy and safety of fenofibrate add-on therapy in patients with primary biliary cholangitis refractory to ursodeoxycholic acid: A retrospective study and updated meta-analysis

• Main Authors: Xuan Guoyun (Author), Ding Dawei (Author), Liu Ning (Author), Hu Yinan (Author), Yang Fangfang (Author), Tian Siyuan (Author), Sun Hao (Author), Yang Jiaqi (Author), Xu Ang (Author), Guo Guanya (Author), Chen Xi (Author), Shang Yulong (Author), Han Ying (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Ursodeoxycholic acid (UDCA) is currently used for the treatment of primary biliary cholangitis (PBC), but some people do not respond well to UDCA. It reported that the combination of fenofibrate and UDCA can improve the clinical indices in these patients. However, more high-quality evide...